|
|
|
Volumn 66, Issue 5, 2014, Pages 497-510
|
|
Drugs developed for treatment of diabetes show protective effects in Alzheimer's and Parkinson's diseases
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EXENDIN 4;
GLUCAGON LIKE PEPTIDE 1;
GLUCAGON RECEPTOR;
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR;
LIRAGLUTIDE;
NEUROPROTECTIVE AGENT;
PEPTIDE;
VENOM;
ZP10A PEPTIDE;
AGONISTS;
ALZHEIMER DISEASE;
ANALOGS AND DERIVATIVES;
ANIMAL;
DIABETES MELLITUS, TYPE 2;
DISEASE MODEL;
HUMAN;
MOUSE;
PARKINSON DISEASE;
TRANSGENIC MOUSE;
ALZHEIMER DISEASE;
ANIMALS;
DIABETES MELLITUS, TYPE 2;
DISEASE MODELS, ANIMAL;
GLUCAGON-LIKE PEPTIDE 1;
HUMANS;
MICE;
MICE, TRANSGENIC;
NEUROPROTECTIVE AGENTS;
PARKINSON DISEASE;
PEPTIDES;
RECEPTORS, GLUCAGON;
VENOMS;
|
|
EID: 84929504903
PISSN: 03710874
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (42)
|
|
References (0)
|